Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Clin Otolaryngol ; 42(2): 366-372, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27542657

ABSTRACT

OBJECTIVES: To explore whether pre-treatment swallowing measures predict swallowing recovery at 6 weeks after transoral robotic surgery (TORS). DESIGN: Prospective cohort study. SETTING: Tertiary care cancer centre in the United Kingdom. PARTICIPANTS: Fifty-one consecutive patients undergoing TORS for head and neck cancer, between April 2013 and February 2015. MAIN OUTCOME MEASURES: Swallowing function assessed by Performance Status Scale (PSS) Normalcy of Diet, timed water swallow test capacity scores (WST) and duration of tube feeding. RESULTS: The primary site distribution was as follows: 21 oropharynx, 8 larynx, 6 mucosectomy and 6 hypopharynx. T stages included 7 staged Tx, 21 T1-T2 tumours and 1 T3 tumour. Moderate-to-severe comorbidity was found in 45/51 patients. Mean PSS score was 83 (sd 27.54); mean WST score was 11.14 (sd 7.97). Most patients (73%) required tube feeding post-operatively, with mean tube feed duration of 18.08 days (sd 17.91); 76% resumed oral intake by 6 weeks. Pre-treatment swallow tests showed moderate negative correlation with tube feeding duration: PSS (rho 0-.430, P = .003); WST (rho 0-.503, P = 0.002). CONCLUSIONS: The majority of TORS patients resume oral intake by 6 weeks. This study shows that impaired swallowing prior to surgery correlates with post-operative duration of tube feeding and strengthens the evidence for the utility of these measures in this clinical setting.


Subject(s)
Deglutition Disorders/physiopathology , Head and Neck Neoplasms/surgery , Robotic Surgical Procedures , Adult , Aged , Aged, 80 and over , Disability Evaluation , Enteral Nutrition , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Preoperative Period , Prospective Studies , Treatment Outcome
2.
J Laryngol Otol ; 129(7): 706-9, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26153839

ABSTRACT

BACKGROUND: Hand-grip strength has been shown to be a reliable predictor of health outcomes. However, evidence supporting its use as an indicator of nutritional status is inconsistent. This study investigated its use in monitoring nutritional status in patients with head and neck cancer. METHODS: A prospective audit of patients treated for head and neck cancer was undertaken at four centres over a three-month period in 2009. Nutritional outcomes were collected at 3, 6 and 12 months, and the data were statistically analysed. RESULTS: Data from 114 patients showed that mean weight, but not hand-grip strength, fell significantly at 3, 6 and 12 months post-treatment (p < 0.003 vs p < 0.126). CONCLUSION: A fall in weight does not coincide with a drop in hand-grip strength in patients receiving treatment for head and neck cancer. Hand-grip strength may therefore not be of benefit in the nutritional assessment of these patients and should not be part of routine assessment.


Subject(s)
Hand Strength/physiology , Head and Neck Neoplasms/physiopathology , Weight Loss/physiology , Adult , Aged , Aged, 80 and over , Female , Head and Neck Neoplasms/therapy , Humans , Male , Middle Aged , Prospective Studies
3.
J Laryngol Otol ; 128(3): 263-7, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24618289

ABSTRACT

BACKGROUND: Many patients treated for head and neck cancer require nutritional support, which is often delivered using a gastrostomy tube. It is difficult to predict which patients will retain their gastrostomy tube in the long term. This study aimed to identify the factors which affect the duration of gastrostomy tube retention. METHOD: In this retrospective study, 151 consecutive patients from one centre were audited. All patients had a mucosal tumour of the head and neck, and underwent gastrostomy tube insertion between 2003 and 2007. RESULTS: There were near-complete data sets for 132 patients. The gastrostomy tube was retained in survivors (n = 66) for a mean of 21.3 months and in non-survivors (n = 66) for 11.9 months. Univariate analysis showed that co-morbidity was the only factor which significantly increased duration of gastrostomy tube retention in survivors (p = 0.041). CONCLUSION: Co-morbidity alone was associated with a significant increase in gastrostomy tube retention. It is suggested that co-morbidity be included as a variable in future relevant research. Co-morbidity should also be considered when counselling patients about their long-term function following cancer treatment. Gastrostomy tube retention is likely to be affected by many factors, with few single variables having importance independently.


Subject(s)
Enteral Nutrition , Gastrostomy , Head and Neck Neoplasms/therapy , Survivors , Adult , Aged , Aged, 80 and over , Alcoholism/epidemiology , Cardiovascular Diseases/epidemiology , Enteral Nutrition/methods , Female , Head and Neck Neoplasms/mortality , Head and Neck Neoplasms/surgery , Humans , Intubation, Gastrointestinal , Male , Medical Audit , Middle Aged , Neoplasm Staging , Pulmonary Disease, Chronic Obstructive/epidemiology , Retrospective Studies , Risk Factors , Time Factors , Treatment Outcome , United Kingdom/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL